|
|
|
«
1-A
B
C-D
E-G
H-L
M
N-O
P
Q-R
S
T-U
V-Z
»
«
Take
Third
»
|
 |
|
|
Takeda Research Investment (TRI)
Offices: Palo Alto, California
Takeda Research Investment is the corporate
venture arm of Takeda Pharmaceutical Company
Limited a world-class pharmaceutical company
and the largest in Japan. A wholly-owned
subsidiary of Takeda America Holdings, TRI
started operations in 2002. Their aim is
to encourage and support therapeutic innovation
in biopharmaceutical companies and academic
centers of excellence, through early stage
capital investment and provision of access
to the resources of a multinational pharmaceutical
company. |
Tate & Lyle Ventures
Offices: London, England
Tate & Lyle Ventures is a £25M venture capital
fund focused on investing in high growth
companies in the fields of renewable ingredients,
food technologies, biomaterials and industrial
processing technologies. They believe that
their insight into financing high growth
businesses coupled with Tate & Lyle's expertise
in bringing new products to market offers
their portfolio companies unique competitive
advantages in building successful independent
ventures. |
Tavistock Life Sciences (TLS)
Offices: Windermere, Florida
Tavistock Life Sciences is a division of
the Tavistock Group, a privately-held organization
whose holdings serve the needs of businesses
and consumers worldwide in life sciences,
financial services, real estate, oil and
gas, leisure services, retailing, and manufacturing.
TLS invests in a select number of life science
opportunities with exceptional technology
profiles. TLS also partners with scientists,
founders, and inventors on compelling early
stage biotech opportunities and enables
all parties to maximize value and wealth
within a stimulating environment. |
Telegraph Hill Partners (THP)
Offices: San Francisco, California
Telegraph Hill Partners is a dedicated life
sciences and healthcare private equity firm
that offers its portfolio companies a superior
combination of extensive partner experience,
longstanding industry relationships and
sound investment knowledge that ultimately
results in more valuable companies. The
THP team collaborates with management to
grow businesses organically as well as through
strategic acquisitions. They aim to gain
liquidity in 3-5 years via an industry sale
or IPO. |
Tenex Medical
Offices: Burlingame, California
Tenex Medical was formed by a group of Silicon
Valley executives to fill a growing need
for early stage investment capital for life
science companies. The Tenex investment
focus is primarily early stage ventures,
whether they are product or company concepts,
which can achieve a meaningful business
benchmark with a capital infusion of between
$250,000 and $750,000 from Tenex. |
The Vertical Group
Offices: Summit, New Jersey & Palo Alto,
California
The Vertical Group is a venture capital
firm that is focused on the fields of medical
technology and biotechnology. The Vertical
Group manages private partnerships with
a "vertical" range of investments in the
medical technology and biotechnology fields.
The Vertical Group's investments include:
early and late venture stage companies;
private operating companies involved in
buy-out or corporate spin-off transactions;
and public companies of all sizes. |
The Column Group
Offices: San Francisco, California
The Column Group will stay committed through
the life cycle of each of its 5 to 8 companies,
and manage risk in each company’s pipeline
rather than through a large portfolio of
companies. They will evaluate the enormous
opportunities in the areas of cancer, inflammation,
infectious disease, metabolic disorders,
cardiovascular disease and nervous system
disorders. The team includes some of today’s
most prominent experts in these medical
fields. |
|
|
|
|
|
|
|
Bio
Life List (Third)
Resources
to
top